We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
-4.8%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$2.35B
AUM Growth
+$754M
(+47%)
Cap. Flow
+$857M
Cap. Flow
% of AUM
36.49%
Top 10 Holdings %
Top 10 Hldgs %
22.96%
Holding
2,090
New
757
Increased
387
Reduced
353
Closed
592
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$290M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$27.1M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$25.8M |
| 4 |
CME Group
CME
|
+$18.4M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$17.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$82.9M |
| 2 |
iShares Silver Trust
SLV
|
+$13.5M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$10.9M |
| 4 |
Apple
AAPL
|
+$9.27M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$7.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.79% |
| 2 | Consumer Discretionary | 10.46% |
| 3 | Healthcare | 9.17% |
| 4 | Financials | 8.81% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Nektar Therapeutics
NKTR
$2.38B
| $181K | 0.01% |
+2,243
| New | +$332K |
|
1327
Barnes & Noble Education
BNED
$447M
| $179K | 0.01% |
501
+266
| +113% | +$142K |
|
1328
Forestar Group
FOR
$1.47B
| $179K | 0.01% |
+10,100
| New | +$189K |
|
|
GAN
1329
DELISTED
GAN Ltd
GAN
| $179K | 0.01% |
37,100
-9,200
| -20% | -$59.2K |
|
|
ONL
1330
Orion Office REIT
ONL
$155M
| $178K | 0.01% |
+12,689
| New | +$214K |
|
1331
Capitol Federal Financial
CFFN
$1.12B
| $177K | 0.01% |
+16,300
| New | +$182K |
|
1332
Vera Bradley
VRA
$99.2M
| $177K | 0.01% |
+23,100
| New | +$183K |
|
|
GRTS
1333
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $175K | 0.01% |
+42,400
| New | +$225K |
|
1334
Viant Technology
DSP
$245M
| $174K | 0.01% |
26,568
+11,668
| +78% | +$89K |
|
|
FRBK
1335
DELISTED
Republic First Bancorp Inc
FRBK
| $174K | 0.01% |
+33,700
| New | +$162K |
|
|
AFMD
1336
DELISTED
Affimed
AFMD
| $173K | 0.01% |
3,950
+2,830
| +253% | +$123K |
|
1337
Purple Innovation
PRPL
$39.2M
| $172K | 0.01% |
+1,175
| New | +$231K |
|
1338
Arbutus Biopharma
ABUS
$861M
| $171K | 0.01% |
57,300
-18,340
| -24% | -$56.1K |
|
1339
Amplify Energy
AMPY
$166M
| $170K | 0.01% |
30,977
-13,923
| -31% | -$64.3K |
|
1340
Vertex
VERX
$2.17B
| $170K | 0.01% |
11,090
-1,710
| -13% | -$23.9K |
|
1341
Arhaus
ARHS
$1.12B
| $168K | 0.01% |
+19,700
| New | +$164K |
|
1342
CytomX Therapeutics
CTMX
$690M
| $168K | 0.01% |
+62,800
| New | +$241K |
|
1343
Scholar Rock
SRRK
$5.49B
| $168K | 0.01% |
+13,000
| New | +$222K |
|
1344
Viking Therapeutics
VKTX
$3.8B
| $168K | 0.01% |
+55,883
| New | +$200K |
|
1345
Heron Therapeutics
HRTX
$96.8M
| $167K | 0.01% |
+29,161
| New | +$213K |
|
1346
Axogen
AXGN
$2.46B
| $164K | 0.01% |
20,700
-18,100
| -47% | -$156K |
|
1347
ClearPoint Neuro
CLPT
$461M
| $164K | 0.01% |
15,800
-5,600
| -26% | -$51K |
|
1348
Olema Pharmaceuticals
OLMA
$985M
| $164K | 0.01% |
38,500
+24,338
| +172% | +$134K |
|
|
SCPL
1349
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $164K | 0.01% |
+12,700
| New | +$160K |
|
|
NAGE
1350
Niagen Bioscience
NAGE
$281M
| $162K | 0.01% |
65,700
+26,800
| +69% | +$73.2K |
|
Similar funds
YAM
ASN
SP
AMH
BIM
CCM
GJL
DKCM
Jump Financial's Q1 2022 Portfolio in Review
As of Q1 2022, Jump Financial held 2,090 positions worth $2.35B, up 47% from $1.59B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jump Financial deployed $857M of net new capital in Q1 2022, opening 757 new positions and adding to 387 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 651,538 shares worth $294M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $10.9M trimmed.
- Jump Financial's largest Q1 2022 buy was State Street SPDR S&P 500 ETF Trust: 651,538 shares worth $294M.
- Jump Financial added most to CME Group in Q1 2022, an estimated $18.4M increase.
- Jump Financial's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $10.9M.
- Jump Financial fully exited Invesco QQQ Trust in Q1 2022, selling an estimated $82.9M.
- Jump Financial's ten largest holdings make up 23% of its $2.35B portfolio in Q1 2022.
- Jump Financial opened 757 new positions and closed 592 in Q1 2022.
- Jump Financial's portfolio value rose 47% quarter-over-quarter to $2.35B.
Based on Jump Financial's 13F filing for Q1 2022, filed 12 May 2022.